Robert Vink Selected Research

Neoplasms (Cancer)

1/2014	Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.
1/2014	Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agents.
4/2013	The potential for substance P antagonists as anti-cancer agents in brain tumours.
7/2011	Salvage surgery for a giant melanoma on the back.
1/2011	Towards drug discovery for brain tumours: interaction of kinins and tumours at the blood brain barrier interface.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Vink Research Topics

Disease

41	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018 - 09/2002
17	Edema (Dropsy) 01/2019 - 11/2005
15	Neurogenic Inflammation 01/2019 - 10/2004
15	Wounds and Injuries (Trauma) 01/2018 - 09/2002
14	Brain Edema (Cerebral Edema) 01/2019 - 11/2005
13	Stroke (Strokes) 01/2019 - 05/2007
13	Brain Injuries (Brain Injury) 01/2017 - 11/2005
7	Inflammation (Inflammations) 10/2016 - 06/2009
7	Spinal Cord Injuries (Spinal Cord Injury) 03/2015 - 09/2009
5	Sudden Infant Death (SID) 11/2018 - 01/2017
5	Parkinson Disease (Parkinson's Disease) 03/2016 - 09/2009
5	Ischemic Stroke 10/2014 - 09/2009
5	Neoplasms (Cancer) 01/2014 - 01/2011
3	Neuroinflammatory Diseases 01/2017 - 06/2009
3	Seizures (Absence Seizure) 03/2016 - 01/2010
3	Hemorrhage 03/2015 - 10/2004
3	Infarction (Infarctions) 01/2015 - 06/2011
2	Asphyxia (Suffocation) 01/2018 - 09/2009
2	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 06/2014
2	Brain Neoplasms (Brain Tumor) 01/2014 - 01/2013
2	Cerebral Hemorrhage 05/2011 - 09/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019
1	Pathologic Processes 01/2019
1	Fatigue 01/2018
1	Airway Obstruction (Choking) 01/2018
1	Tachycardia (Tachyarrhythmias) 01/2018
1	Craniocerebral Trauma (Head Injury) 01/2018
1	Multiple Abnormalities 10/2017
1	Diffuse Brain Injuries (Diffuse Brain Injury) 08/2017
1	Nephrosis 01/2017
1	Diabetes Mellitus 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Tension-Type Headache (Tension Headache) 03/2016
1	Flushing 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2015
1	Spinal Cord Compression 04/2015

Drug/Important Bio-Agent (IBA)

32	Substance PIBA 01/2019 - 10/2004
16	NeuropeptidesIBA 01/2017 - 01/2007
13	MagnesiumIBA 08/2017 - 01/2003
9	TachykininsIBA 01/2019 - 06/2010
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2006
8	Amyloid (Amyloid Fibrils)IBA 01/2018 - 06/2006
7	Tryptophan (L-Tryptophan)FDA Link 08/2017 - 08/2009
6	Tachykinin Receptors (Tachykinin Receptor)IBA 08/2017 - 05/2011
6	N-acetyltalosaminuronic acid (NAT)IBA 10/2014 - 02/2011
5	AlbuminsIBA 03/2015 - 05/2011
4	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2012
4	Inosine Triphosphate (ITP)IBA 03/2015 - 01/2013
4	KininsIBA 01/2011 - 06/2009
3	Neurotransmitter Agents (Neurotransmitter)IBA 08/2018 - 01/2007
3	Pharmaceutical PreparationsIBA 01/2018 - 06/2009
3	SaltsIBA 03/2016 - 10/2004
3	Caspase 3 (Caspase-3)IBA 04/2015 - 09/2002
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014 - 09/2012
2	Serotonin (5 Hydroxytryptamine)IBA 08/2018 - 10/2017
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2017 - 01/2010
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2016 - 09/2009
2	CytokinesIBA 01/2016 - 06/2009
2	Aquaporins (Water Channels)IBA 11/2013 - 06/2010
2	Evans Blue (Blue, Evans)FDA Link 01/2013 - 01/2010
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2012 - 08/2010
2	Messenger RNA (mRNA)IBA 10/2010 - 09/2009
2	Progesterone FDA LinkGeneric 05/2007 - 11/2005
1	Aligeron (AS 2)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018
1	AmphetaminesIBA 01/2018
1	Carbon DioxideIBA 01/2018
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2018
1	Toll-Like Receptor 4IBA 08/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	GlycogenIBA 01/2017
1	Monoamine Oxidase (MAO)IBA 01/2017
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2017
1	ProstaglandinsIBA 10/2016
1	BradykininIBA 10/2016
1	Neuroprotective AgentsIBA 10/2016
1	threonic acid (threonate)IBA 03/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	InterferonsIBA 01/2016
1	Interleukin-2 (IL2)IBA 01/2016
1	InterleukinsIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Interleukin-13IBA 01/2016
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	DNA-Activated Protein KinaseIBA 04/2015
1	TransferasesIBA 04/2015
1	Apoptosis Inducing FactorIBA 04/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2015

Therapy/Procedure

12	Therapeutics 01/2019 - 10/2002
2	Drug Therapy (Chemotherapy) 01/2014 - 10/2002
1	Decompressive Craniectomy 01/2019
1	General Anesthesia 01/2018
1	Intravenous Administration 01/2018